Renal Colic

8

Review clinical trials related to Renal Colic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

Participants needed: 86
Trial details
Phase: Phase 4Age: 18-65Biological sex: AllType: InterventionalSponsor: Hackensack Meridian HealthUpdated: May 22, 2026Locations: 1
Eligibility criteria

Adult emergency department patients < 65 years old [+3]

Allergy to ketorolac [+6]

Status: Not yet recruiting

Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED

Adult patients (18-55 years of age) with clinical diagnosis of acute renal colic (sudden sharp colic flank pain with or without radiation to genitalia or groin and with or without urinary symptoms) who had pain score of 5 or more measured by 10-cm visual analogue scale (VAS), will be included. Will be excluded those who had history of cardiovascular, hepatic, renal or metabolic diseases, patients with evidence of sepsis or clinical suspicion of urinary tract infection, hemodynamically unstable patients (systolic blood pressure \&amp;lt;90 mmHg), patients with uncontrolled diabetes, pregnancy, breastfeeding, patients unable to understand verbal and/or written information, patients receiving analgesics within 6 hours before presentation, serum potassium less than 3.7 mmol/l, concomitant use of any beta blockers (including beta-blocker containing eye drops), prolonged-release long-acting β-agonists, use of short-acting β2-agonists within the 6 h preceding presentation to the emergency department, any contraindication to the use of terbutaline, history of drug dependence or chronic consumption of alcohol. Will be also excluded patients with known allergy to paracetamol or terbutaline, patients with abdominal tenderness as a sign of peritoneal inflammation and those with any clinical suspicion for diseases other than urolithiasis, including abdominal aortic aneurysm or dissection.

Participants needed: 300
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: University of MonastirUpdated: May 20, 2026Locations: 1
Eligibility criteria

Adults aged 18-65 years [+2]

History of cardiovascular, hepatic, renal, or metabolic diseases [+13]

Status: Not yet recruiting

Relief Efficacy of Lidocaine Versus Morphine for Acute Renal Colic in the Emergency Department

The opioid epidemic continues to be a major public health crisis in the United States. According to the Center for Disease Control, approximately 8 million Americans reported misusing prescription opioids in 2023, with over 5 million Americans reporting that they suffer from opioid use disorder. The United States government estimates that 105,000 people died from drug overdose in 2023, and approximately 80,000 of those deaths can be attributed to opioids (\~76%). In acknowledgement of the opioid crisis, we wish to contribute to ongoing efforts to reduce unnecessary and excessive opioid prescription. In 2012, researchers in Iran published a randomized controlled trial comparing intravenous (IV) lidocaine to IV morphine for acute renal colic, reporting that 90% patients responded "successfully" in the lidocaine group versus 70% in the morphine group. They also concluded that there was a statistically significant difference between pain scores between the two groups at all time points, favoring the lidocaine group. However, the study was conducted at a single emergency department in Tabriz, Iran, with a relatively homogenous patient population, and the researchers did not explicitly define their primary outcome variable for what constituted a "successful" response in the treatment groups. The investigators of this study aim to build upon this preliminary evidence by recruiting a more diverse population to improve generalizability and by predefining pain-reduction thresholds to allow for more meaningful comparison between the interventions.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Loma Linda UniversityUpdated: Apr 17, 2026
Eligibility criteria

Age ≥ 18 years at time of visit [+3]

Age < 18 years [+9]

Status: Recruiting

Ear Pressure Points Plus Pain Meds for Faster Kidney Stone Pain Relief

Title: Can Ear Acupressure Help Relieve Kidney Stone Pain Faster When Combined with Painkillers? Purpose: This study tests whether adding ear acupressure to standard painkillers (NSAIDs) helps adults with kidney stone pain feel better faster. The investigators also want to know if this combination causes any side effects. Key Questions: Does ear acupressure + NSAIDs reduce pain more quickly than NSAIDs alone? Are there any safety concerns with this treatment? How does real ear acupressure compare to a fake (placebo) procedure? Who Can Join? Adults aged 18-75 Experiencing moderate-to-severe kidney stone pain (confirmed by CT or ultrasound) No recent painkiller use or allergies to NSAIDs What Participants Will Do: Receive in the emergency room: Real treatment: Tiny needles placed on 3 ear points + NSAIDs (ketorolac injection) OR Placebo treatment: Fake tape on ear points + NSAIDs (same injection) Rate their pain on a 0-10 scale over 60 minutes. Have their heart rate and blood pressure checked. Study Details: Duration: Single ER visit (no long-term follow-up) Participants Needed: 116 Safety: Rescue pain medication (like morphine) is available if needed. Why This Matters: Kidney stones cause severe pain, and current painkillers may not work fast enough. Ear acupressure is a low-risk method from traditional Chinese medicine that could provide quicker relief. Ethics: Approved by Changhai Hospital's Ethics Committee. Participants can leave the study anytime.

Participants needed: 116
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Gao XiaofengUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Age between 15 and 75 years (inclusive) [+4]

Use of any analgesic medication within the past 6 hours. [+6]

Status: Not yet recruiting

Analgesic Efficacy of Transcutaneous Electrical Nerve Stimulation and Dexketoprofen in Renal Colic

The aim of this study was to compare the analgesic efficacy of transcutaneous electrical nerve stimulation (TENS) and dexketoprofen trometamol in patients presenting to the emergency department due to renal colic.

Participants needed: 128
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Adiyaman University Research HospitalUpdated: Oct 2, 2025Locations: 1
Eligibility criteria

Patients who refuse to participate in the study [+7]

Status: Recruiting

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients

Participants needed: 92
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Community Medical Center, Toms River, NJUpdated: Jul 17, 2025Locations: 1
Eligibility criteria

Patient self-reported history of nephrolithiasis [+8]

Age < 18 years [+10]

Status: Recruiting

Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic

This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.

Participants needed: 1,500
Trial details
Phase: Phase 2Age: 18-99Biological sex: AllType: InterventionalSponsor: University of MonastirUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

-Age > 18 years old. [+3]

-Inability to appreciate pain according to the VAS. [+2]

Status: Recruiting

Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics

Treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this subject. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency department after the first line treatment of a renal colic investigating the reccurence of pain, the reconsultation rates and the admissions.

Participants needed: 500
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of MonastirUpdated: Nov 14, 2023Locations: 1
Eligibility criteria

Over 18 years old [+3]

Contraindication of NSAI treatment [+2]